Lv1
60 积分 2024-04-30 加入
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer
10小时前
已完结
Spatiotemporal Quantification of HER2-targeting Antibody–Drug Conjugate Bystander Activity and Enhancement of Solid Tumor Penetration
23天前
已完结
Molecular classification of hormone receptor-positive HER2-negative breast cancer
1年前
已完结
医疗机构内研究者发起临床研究的项目管理思考
1年前
已完结
研究者发起的临床研究规范化管理的现状,优势和难点分析
1年前
已完结
皖公网安备34019202002308
